Trial
NCT00745030
Efficacy and Tolerability of Ramelteon in Patients With Rapid Eye Movement (REM) Behavior Disorder and Parkinsonism
UnknownTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Northwestern University
Collaborators
Takeda
Condition
REM Behavior Disorder
Intervention
Rozerem
Why stopped
Low subject recruitment and enrollment.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-01-09